Litigators of the Week Runners-Up and Shout-Outs — Novo Nordisk
A Latham Securities and M&A Litigation team achieved a win in the Delaware Court of Chancery on behalf of client Novo Nordisk.
Latham securities litigators prevail decisively in high-stakes M&A litigation in the Delaware Court of Chancery and in other state and federal jurisdictions across the country, winning at the preliminary injunction stage, at trial, and on appeal. We handle disputes arising out of public and private company transactions alike, including corporate control litigation, director and shareholder disputes, earn-outs, and breach of contract actions.
We have demonstrated prowess in taking “entire fairness” cases to trial in Delaware — and winning. Before trial, Latham frequently achieves dismissals of stockholder cases through motions to dismiss, and our victories are routinely affirmed by the Delaware Supreme Court.
The leading plaintiffs’ firms in this space know that we will take cases to trial and win. Our track record and reputation before the Delaware Court of Chancery allow us to effectively advocate for our clients’ interests in even the most complex corporate control disputes, hostile takeovers, and activism defense cases.
To ensure that clients are prepared for any such litigation, Latham litigators consult early with potential acquirers, targets, and financial advisors on issues including deal protection measures, conflicts of interest, change-of-control payments, and disclosure obligations. We handle all types of litigation that can arise both pre- and post-signing, including:
We work hand-in-hand with clients to achieve the deal they desire, enforce their rights, and ensure that litigation does not interfere with their business goals. Doing so may mean defeating plaintiffs’ attempts to materially impact the transaction and preserving the shareholders’ ability to vote on the deal or choose whether to tender their shares, or successfully appealing to the courts to enforce or alter the transaction.
A Latham Securities and M&A Litigation team achieved a win in the Delaware Court of Chancery on behalf of client Novo Nordisk.
Two Latham Securities and M&A Litigation teams notched wins in Delaware Chancery Court: one successfully voided board changes on behalf of minority shareholders in a Section 225 action, and another secured dismissal of all claims for a client group affiliated with private equity firms in a de-SPAC case.
Litigation & Trial partner recognized for his successes in high-stakes white collar and civil litigation matters and leadership within the firm and broader legal community.